South Dakota Investment Council raised its stake in shares of Danaher Co. (NYSE:DHR – Free Report) by 5.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 12,682 shares of the conglomerate’s stock after acquiring an additional 700 shares during the quarter. South Dakota Investment Council’s holdings in Danaher were worth $2,911,000 at the end of the most recent quarter.
A number of other large investors also recently modified their holdings of DHR. Heck Capital Advisors LLC bought a new position in shares of Danaher in the 4th quarter worth about $27,000. Decker Retirement Planning Inc. bought a new position in shares of Danaher in the 4th quarter worth about $31,000. Golden State Wealth Management LLC bought a new position in shares of Danaher in the 4th quarter worth about $31,000. Strategic Financial Concepts LLC bought a new position in shares of Danaher in the 4th quarter worth about $31,000. Finally, Pineridge Advisors LLC lifted its position in shares of Danaher by 63.3% in the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after buying an additional 57 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.
Insider Activity
In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Insiders own 11.10% of the company’s stock.
Wall Street Analysts Forecast Growth
Check Out Our Latest Analysis on DHR
Danaher Stock Performance
NYSE:DHR opened at $209.86 on Monday. Danaher Co. has a twelve month low of $196.80 and a twelve month high of $281.70. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The company has a 50-day moving average of $226.71 and a 200-day moving average of $246.84. The firm has a market cap of $151.58 billion, a price-to-earnings ratio of 39.75, a price-to-earnings-growth ratio of 2.66 and a beta of 0.83.
Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter last year, the business posted $2.09 earnings per share. Analysts forecast that Danaher Co. will post 7.63 earnings per share for the current fiscal year.
Danaher Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a dividend of $0.32 per share. This is a positive change from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a dividend yield of 0.61%. Danaher’s dividend payout ratio (DPR) is 20.45%.
Danaher Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Recommended Stories
- Five stocks we like better than Danaher
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- How is Compound Interest Calculated?
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- What is a Death Cross in Stocks?
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.